Patient Leaflet Updated 01-Sep-2025 | AFT Pharma UK Ltd
Combogesic IV 10 mg/ml + 3 mg/ml [1000mg / 300mg in 100ml] solution for infusion
Combogesic IV 10 mg/ml + 3 mg/ml [1000mg / 300mg in 100ml] solution for infusion
Paracetamol/Ibuprofen
1. What Combogesic IV is and what it is used for
2. What you need to know before you are given Combogesic IV
3. How you are given Combogesic IV
4. Possible side effects
5. How to store Combogesic IV
6. Contents of the pack and other information
Combogesic IV contains the active substances paracetamol and ibuprofen. Ibuprofen belongs to a group of medicines called non-steroidal anti-inflammatory drugs (or NSAIDs). Paracetamol works in a different way to ibuprofen, but both substances work together to reduce pain.
Combogesic IV is used in adults for the short-term symptomatic treatment of acute moderate pain and the reduction of fever, where an intravenous route of administration is necessary and/or when other routes of administration are not possible.
Do not take anything else containing paracetamol while taking this medicine.
In order to avoid the risk of overdose,
During treatment with Combogesic IV, tell your doctor straight away if:
If you have severe illnesses, including severe renal impairment or sepsis (when bacteria and their toxins circulate in the blood leading to organ damage), or you suffer from malnutrition, chronic alcoholism or if you are also taking flucloxacillin (an antibiotic). A serious condition called metabolic acidosis (a blood and fluid abnormality) has been reported in patients in these situations when paracetamol is used at regular doses for a prolonged period or when paracetamol is taken together with flucloxacillin. Symptoms of metabolic acidosis may include: serious breathing difficulties with deep rapid breathing, drowsiness, feeling sick (nausea) and being sick (vomiting).
If you are taking Combogesic IV for longer than the recommended time or at higher than recommended doses you are at risk of serious harms. These include serious harms to the stomach/gut and kidneys, as well as very low levels of potassium in your blood. These can be fatal (see section 4)
Side effects may be minimised by using the minimum effective dose for the shortest duration necessary to control symptoms. Do not use Combogesic IV for more than 2 days.
Talk to your doctor or nurse before you are given Combogesic IV if:
Cardiovascular risk
Anti-inflammatory/pain-killer medicines like ibuprofen may be associated with a small increased risk of heart attack or stroke, particularly when used at high doses. Do not exceed the recommended dose or duration of treatment.
Gastrointestinal symptoms
Serious gastrointestinal side effects (affecting the stomach and intestines) have been reported with the use of NSAIDs, including ibuprofen. These can occur with or without warning symptoms. The risk of these side effects is higher in patients with a history of ulcers of the stomach or intestines, particularly if bleeding or perforation was also involved. Elderly patients are at greater risk of gastrointestinal side effects. You should discuss any history of gastrointestinal problems with your doctor, and remain alert for any unusual abdominal symptoms, including nausea, vomiting, diarrhoea, constipation, indigestion, abdominal pain, tar-like stools, or vomiting blood.
Elderly patients should first discuss treatment with a doctor. Elderly patients are at greater risk of side effects, especially bleeding and perforation in the digestive tract.
Skin reactions
Serious skin reactions have been reported in association with ibuprofen treatment. You should tell your doctor or nurse immediately if you develop any skin rash, lesions of the mucous membranes, blisters or other signs of allergy since these can be the first signs of a very serious skin reaction. See section 4.
Infections
Combogesic IV may hide signs of infections such as fever and pain. It is therefore possible that Combogesic IV may delay appropriate treatment of infection, which may lead to an increased risk of complications. This has been observed in pneumonia caused by bacteria and bacterial skin infections related to chickenpox. If you are given this medicine while you have an infection and your symptoms of the infection persist or worsen, consult a doctor without delay.
Prolonged use of painkillers
If you use painkillers for a long time, this can cause headaches, which should not be treated with more painkillers. If you think this applies to you, talk to your doctor or pharmacist.
Vision problems
If you notice any problems with your vision after using Combogesic IV, stop using the medicine and see a doctor.
Combogesic IV is not for use in children and adolescents under 18 years.
Tell your doctor or nurse if you are taking, have recently taken, or might take any other medicines.
Always tell the doctor if you are taking other medicines containing paracetamol, ibuprofen or other NSAID painkillers, including those you can buy without a prescription. This is to avoid the risk of overdose.
Combogesic IV may affect or be affected by some other medicines. For example:
Some other medicines may also affect or be affected by the treatment of Combogesic IV. You should therefore always seek the advice of your doctor, nurse or pharmacist before you take any other medicines.
If you need to leave a blood or urine sample for analysis, you need to tell your doctor that you are taking this medicine as it may interfere with the test results.
Do not drink alcoholic beverages when treated with this medicine. Combining alcohol with Combogesic IV may lead to liver damage.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or nurse for advice before this medicine is given to you.
Pregnancy
Do not take Combogesic IV if you are in the last 3 months of pregnancy as it could harm your unborn child or cause problems at delivery. It can cause kidney and heart problems in your unborn baby. It may affect your and your baby’s tendency to bleed and cause labour to be later or longer than expected. You should not take Combogesic IV during the first 6 months of pregnancy unless absolutely necessary and advised by your doctor. If you need treatment during this period or while you are trying to get pregnant, the lowest dose for the shortest time possible should be used. If taken for more than a few days from 20 weeks of pregnancy onward, Combogesic IV can cause kidney problems in your unborn baby that may lead to low levels of amniotic fluid that surrounds the baby (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the heart of the baby. If you need treatment for longer than a few days, your doctor may recommend additional monitoring.
Breast-feeding
Only small amounts of paracetamol and ibuprofen pass into breast milk. This medicine may be given during breast-feeding, if it is used at the recommended dose and for the shortest possible time.
Fertility
This product may impair female fertility and is not recommended in women attempting to conceive. This effect is reversible on stopping the medicine.
Undesirable effects such as dizziness, drowsiness, fatigue and visual disturbances are possible after taking NSAIDs. If affected you should not drive or operate machinery.
Combogesic IV contains 35 mg sodium (main component of cooking/table salt) in each 100 ml. This is equivalent to 1.75% of the recommended maximum daily dietary intake of sodium for an adult.
Combogesic IV will be given to you by a healthcare professional by infusion into one of your veins. The infusion should be administered over 15 minutes.
This medicine is for short term use only, maximum 2 days.
For adults who weigh more than 50 kg: 1 vial every 6 hours, as required.
The maximum daily dose is four vials which equals 4000 mg (4 g) paracetamol and 1200 mg ibuprofen.
If you weigh 50 kg or less, are elderly or if you have liver or kidney problems: Your doctor may decide to reduce your dose or increase the time between doses because of the increased risk of side effects.
Do not take more medicine than the label tells you to. If you do not get better, talk to your doctor.
A higher dose than the recommended does not increase pain relief; instead it can lead to serious risks (see also section “If you are given more Combogesic IV than you should”). The lowest effective dose should be given for the shortest duration necessary to relieve symptoms. If you have an infection, consult a doctor without delay if symptoms (such as fever and pain) persist or worsen (see section 2).
Immediately contact a doctor or nurse if you think that you accidentally may have been given too much of this medicine. Do this even if you feel well. This is because too much paracetamol can cause delayed, serious liver damage, which may be fatal. Even if there are no signs of discomfort or poisoning, you may need urgent medical attention.
In order to avoid liver damage it is essential to get medical treatment as early as possible. The shorter the interval between intake and initiation of treatment with antidote (as few hours as possible), the greater the likelihood that hepatic injury can be prevented.
Further symptoms can include nausea, stomach pain, vomiting (may be blood streaked), headache, ringing in the ears, confusion and shaky eye movement. At high doses, drowsiness, chest pain, palpitations, loss of consciousness, convulsions (mainly in children), weakness and dizziness, blood in urine, cold body feeling, and breathing problems have been reported.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop using Combogesic IV and tell your doctor immediately or go to the emergency room at your nearest hospital if you get any of the following side effects:
Uncommon:
Very rare:
Not known (frequency cannot be estimated from the available data):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provided more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children and adolescents.
Store below 25°C. Do not refrigerate or freeze. Store in the original carton in order to protect from light.
Do not use this medicine after the expiry date which is stated on the carton and on the vial after EXP. The expiry date refers to the last day of that month.
Do not use this medicine if you notice the packaging is torn or shows signs of tampering. Do not use this medicine if you notice any visible particles or discolouration.
This product is for single use only. The product should be used immediately after opening. Any unused solution should be discarded.
Dispose in accordance with local requirements.
The active substances are 10 mg/ml paracetamol and 3 mg/ml ibuprofen (as sodium dihydrate).
The other ingredients are cysteine hydrochloride monohydrate, disodium phosphate dihydrate, mannitol, hydrochloric acid (for pH adjustment), sodium hydroxide (for pH adjustment), and water for injections.
Combogesic IV is a clear, colourless solution for infusion, free from visible particles. It is supplied in 100 ml clear glass vials, closed with a grey bromobutyl rubber stopper and an aluminium flip-off cap. It comes in a pack size of 10 vials.
Marketing Authorisation Holder:
Manufacturer:
This leaflet was last revised in June 2025
PL 57592/0001
Olympia House, Unit 13 2nd Floor, Armitage Road,, London, NW11 8RQ, UK
+44 (0)1934 838 820